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most important response is to offer a
sound base of support for combating
emerging diseases where they start,
relying less on the rapid influx of
international experts and the long-dis-
tance shipping of specimens and more
on “home grown” talent, equipped
with the tools and training that they
need. Achieving these goals will be
difficult. Beyond supplying medicine
and laboratory equipment, tackling the
problem will require addressing such
complex issues as low salaries and
“brain drain,” civil unrest, corruption,
and human rights. Dr. Conteh was
exceptional because he persisted in the
face of these challenges, but we can-
not routinely depend on such heroes.
Governments in developing countries,
with international support, need to
build the base to create stable job and
training opportunities, adequate physi-
cal infrastructure, and safe working
environments to foster the develop-
ment of local expertise and encourage
local physicians and scientists to help
fill the role vacated by Dr. Conteh.
Ultimately, containing emerging dis-
eases depends on the Aniru Contehs of
the world. The more support we pro-
vide to people on the front lines, the
healthier and safer we all will be.
Aniru Conteh is survived by his
wife, Sarah, three sons, and two
daughters.
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In “SARS-CoVAntibody Prevalence in All Hong Kong
Patient Contacts” by Gabriel M. Leung et al., errors
occurred on p. 1654. The seventh sentence read “those who
declined testing” but should have been “those who consent-
ed to testing.” 
The corrected sentence reads as follows: However,
those who consented to testing were more likely to report
more frequent contact and closer relationships with SARS
patients, more febrile or respiratory illness episodes since
February, and a travel history to SARS-affected regions,
which may have biased our seroprevalence estimate
upwards.
The corrected article appears online at http://www.cdc.
gov/ncidod/EID/vol10no9/02-0155.htm
We regret any confusion these errors may have caused.